Arbutus Biopharma Corp Balance Sheet
ABUS / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Arbutus Biopharma Corp had $95M in total assets and $77M in shareholders' equity as of FY2025. Total debt was $0 against $18M in cash, resulting in a $18M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18.0M | $36.3M | $26.3M | $30.8M | $109.3M | $52.3M | $31.8M | $54.3M | $54.3M | $23.4M | $166.8M | $72.2M | $68.7M | $47.0M | $9.0M |
| Accounts Receivable | $1.4M | $2.4M | $1.8M | $1.4M | $899.0K | $1.3M | $1.2M | $1.4M | $402.0K | $273.0K | $1.0M | $1.9M | $117.0K | $1.1M | - |
| Current Assets | $94.5M | $127.3M | $132.0M | $151.1M | $160.7M | $127.7M | $93.8M | $129.2M | $129.4M | $132.6M | $183.9M | $116.4M | $70.3M | - | - |
| PP&E (Net) | $32.0K | $3.3M | $4.7M | $5.1M | $6.0M | $6.9M | $8.7M | $10.1M | $12.2M | $6.9M | $3.2M | $1.8M | $1.4M | - | - |
| Goodwill | - | - | - | - | - | - | $0 | $22.5M | $24.4M | $24.4M | $162.5M | - | - | - | - |
| Total Assets | $94.6M | $131.7M | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M | $237.2M | $275.9M | $712.3M | $118.2M | $71.7M | - | - |
| Current Liabilities | $6.0M | $15.6M | $22.5M | $32.9M | $11.2M | $9.5M | $7.8M | $11.2M | $14.6M | $10.6M | $10.6M | $20.2M | $12.5M | - | - |
| Total Debt | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $76.6M | $97.4M | $106.0M | $136.9M | $169.4M | $72.7M | $200.2M | $182.5M | $182.5M | $203.0M | $547.7M | $88.0M | $59.2M | $40.9M | $5.2M |